Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 8, Issue 6, pp. 1589-1595
PubMed
Published By
Print ISSN
Online ISSN
History
- January 15, 2009
- March 2, 2009
- March 3, 2009
- Published first June 9, 2009.
Article Versions
- Previous version (June 9, 2009 - 10:03).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2009 American Association for Cancer Research.
Author Information
- Andrew Baschnagel1,
- Andrea Russo1,
- William E. Burgan2,4,
- Donna Carter2,4,
- Katie Beam2,3,
- Diane Palmieri3,
- Patricia S. Steeg3,
- Philip Tofilon5 and
- Kevin Camphausen1
- 1Radiation Oncology Branch, 2Molecular Radiation Therapeutics Branch, and 3Laboratory of Molecular Pharmacology, National Cancer Institute, Bethesda, Maryland; 4Science Applications International Corporation-Frederick, National Cancer Institute-Frederick, Frederick, Maryland; and 5Drug Discovery Program, H. Lee Moffitt Cancer Center, Tampa, Florida
- Requests for reprints: Kevin Camphausen, Radiation Oncology Branch, National Cancer Institute, 10 Center Drive, Building 10, CRC, Room B2-3561, Bethesda, MD 20892. Phone: 301-496-4146; Fax: 301-480-1434. E-mail: camphauk{at}mail.nih.gov
June 2009
Volume 8, Issue 6
Volume 8, Issue 6
Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts
Jump to section
Advertisement